Documentation Centre

April 09, 2018
Diabetes: Metformin - a cardiovascular moderator of DPP4 inhibitors? Nat Rev Endocrinol. 2018;14:8-9
Scheen AJ

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Clinical Trials, Cardiovascular Disease, Diabetes